Sigma-Tau Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 0 PAGES: 37

More Info
									       Sigma-Tau Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and
                                   Alliances Profile
       Reference Code: GDPH189891D                                                                                                                 Publication Date: JAN 2013

      Company Overview                                                                                            Key Facts
      Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) is a biotechnology company, based
                                                                                                                  Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals
      in the US. The company discovers and develops used to treat rare diseases. It
                                                                                                                  & Healthcare, Key Facts
      operates through its product segments such as prescription products and consumer
      products. Sigma-Tau offers prescription products such as adagen, matulane,                                   Web Address                        www.sigmatau.com
      carnitor, oncaspar, depocyt, and abelcet. The company through its consumer
                                                                                                                   Revenue (US$ million)                             NA
      product segment produces non-prescription medicines and dietary supplements,
      which include proxeed plus a male fertility supplement and vsl#3 a medical food for                          Number of Employees                               NA
      patients with an ileal pouch (IP), irritable bowel syndrome and ulcerative colitis (UC).                     GlobalData
      It operates as subsidiary of Sigma-Tau S.p.A.

      Financial Deals Landscape
        Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals & Healthcare,                    Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals &
        Deals by Type, 2007 to YTD 2013                                                   Healthcare, Deals By Year, 2007 to YTD 2013

                                                                                                          8
                                                                                                                                         6


                                                                                           No. of Deals
                                                                                                          6

                                                                                                          4                                   3
                                                                                                                     2         2                      2
                                                                                                          2
                                                                                                                                                               0         0
                                                                                                          0
                                                                                                                   2007       2008   2009    2010    2011     2012   YTD
                                                                                                                                                                     2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from        from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals &                               Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013

                         16     14                                                                        10              9
          No. of Deals




                         14
                                                                                           No. of Deals




                         12                                                                                   8
                                                                                                                                     6
                         10
                          8                                                                                   6
                                                                                                                                               4          4
                          6                                                                                   4                                                      3
                          4              2
                                                  1
                          2                                 0         0                                       2
                          0
                              North    Europe   South      Asia-    Middle                                    0
                              Americ             and      Pacific    East                                            Gastroi Oncolo          Immun Infectio Metabo
                                a               Central              and                                             ntestin   gy             ology   us      lic
                                                Americ              Africa                                              al                          Diseas Disord
                                                  a                                                                                                    e     ers



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Sigma-Tau Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare -                                                                                    Reference Code: GDPH189891D
Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                      Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ............................................. 3
       Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ............................................. 5
       Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ......................................... 6
       Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ............................... 7
       Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 .......................................... 8
       Sigma-Tau Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details ............................................................................. 10
          Asset Purchase............................................................................................................................................................................. 10
             Sigma-Tau Acquires Specialty Pharma Business From Enzon Pharma ................................................................................... 10
             Sigma-Tau Pharma Acquires Chenix From Solvay Pharma...................................................................................................... 13
             Sigma-Tau Pharma Acquires Chenofalk ................................................................................................................................... 14
          Partnerships.................................................................................................................................................................................. 15
             Endotis Pharma Enters Into Co-development Agreement With Tecnogen ................................................................................ 15
             Sigma-Tau Pharma Signs Partnership Agreement With Danisco Bioactive .............................................................................. 17
             Walter Reed Army Institute of Research And U.S. Army Medical Materiel Development Activity Form Partnership With Sigma-
             Tau Pharma .............................................................................................................................................................................. 18
          Licensing Agreements .................................................................................................................................................................. 19
             Soligenix Expands Licensing Agreement With Sigma-Tau Pharma For orBec ......................................................................... 19
             Gentium Enters Into Licensing Agreement With Sigma-Tau Pharma........................................................................................ 20
             DOR BioPharma Enters Into Licensing Agreement With Sigma-Tau Pharma For orBec .......................................................... 22
          Equity Offering .............................................................................................................................................................................. 23
             RegeneRx BioPharma Completes Registered Direct Offering Of $1.45 Million ........................................................................ 23
             Soligenix Completes Private Placement Of Its Common Stock For $6 Million .......................................................................... 25
             DOR BioPharma Completes Private Placement Of $4.39 Million...
								
To top